Brown Advisory Inc. Sells 36,965 Shares of Danaher Corporation (NYSE:DHR)

Brown Advisory Inc. trimmed its stake in Danaher Corporation (NYSE:DHR - Free Report) by 1.0% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 3,743,137 shares of the conglomerate's stock after selling 36,965 shares during the period. Danaher makes up about 1.1% of Brown Advisory Inc.'s portfolio, making the stock its 22nd biggest position. Brown Advisory Inc. owned about 0.52% of Danaher worth $767,343,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also modified their holdings of DHR. GHP Investment Advisors Inc. lifted its stake in shares of Danaher by 396.0% during the 1st quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate's stock worth $25,000 after acquiring an additional 99 shares during the last quarter. Heck Capital Advisors LLC bought a new stake in shares of Danaher during the 4th quarter worth approximately $27,000. Sierra Ocean LLC lifted its stake in shares of Danaher by 116.9% during the 1st quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate's stock worth $29,000 after acquiring an additional 76 shares during the last quarter. Smallwood Wealth Investment Management LLC bought a new stake in shares of Danaher during the 1st quarter worth approximately $31,000. Finally, Rialto Wealth Management LLC bought a new stake in shares of Danaher during the 4th quarter worth approximately $34,000. 79.05% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several research analysts have commented on the company. UBS Group reduced their price objective on Danaher from $275.00 to $240.00 and set a "buy" rating on the stock in a report on Wednesday, April 23rd. Evercore ISI reduced their price objective on Danaher from $240.00 to $230.00 and set an "outperform" rating on the stock in a report on Tuesday, April 22nd. The Goldman Sachs Group cut their price target on Danaher from $260.00 to $240.00 and set a "neutral" rating on the stock in a report on Wednesday, April 23rd. HSBC cut their price target on Danaher from $270.00 to $240.00 in a report on Friday, April 25th. Finally, Robert W. Baird cut their price target on Danaher from $231.00 to $225.00 and set an "outperform" rating on the stock in a report on Wednesday, April 23rd. Four equities research analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and an average target price of $248.61.

Danaher Price Performance

NYSE:DHR opened at $199.60 on Tuesday. Danaher Corporation has a 12 month low of $171.00 and a 12 month high of $281.70. The stock has a 50 day moving average of $195.71 and a two-hundred day moving average of $206.90. The company has a current ratio of 1.43, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. The firm has a market cap of $142.85 billion, a P/E ratio of 38.76, a price-to-earnings-growth ratio of 2.85 and a beta of 0.77.

Danaher (NYSE:DHR - Get Free Report) last posted its quarterly earnings data on Tuesday, April 22nd. The conglomerate reported $1.88 EPS for the quarter, topping the consensus estimate of $1.62 by $0.26. The company had revenue of $5.74 billion during the quarter, compared to analyst estimates of $5.58 billion. Danaher had a return on equity of 10.80% and a net margin of 15.81%. On average, analysts expect that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be issued a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a yield of 0.64%. Danaher's dividend payout ratio is presently 24.85%.

Insider Buying and Selling

In related news, Chairman Steven M. Rales sold 1,250,000 shares of the company's stock in a transaction that occurred on Monday, May 12th. The stock was sold at an average price of $196.74, for a total value of $245,925,000.00. Following the transaction, the chairman directly owned 3,105,808 shares in the company, valued at approximately $611,036,665.92. This represents a 28.70% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP Christopher Paul Riley sold 15,805 shares of the company's stock in a transaction that occurred on Wednesday, April 30th. The shares were sold at an average price of $198.00, for a total value of $3,129,390.00. Following the completion of the transaction, the executive vice president owned 15,179 shares in the company, valued at $3,005,442. This represents a 51.01% decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 11.20% of the company's stock.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.